Research Highlight Published: March 2007 Neurodegenerative disorders Pathways to treatment Katherine Whalley Nature Reviews Neuroscience 8, 287–299 (2007) Cite this article ...

Rutgers scientists have uncovered a tug-of-war inside the brain between hunger and satiety, revealing two newly mapped neural ...

Transcriptomics, lipidomics, and kinase arrays in preclinical models demonstrated that SCD1 inhibition promoted ferroptosis, altered fatty acid metabolism, and downregulated SLC7A11 via AKT-GSK3β-NRF2 ...

Gut bacteria produce 90% of serotonin and affect mental health. Why digestive dysfunction might be causing anxiety and ...

Combining omega-3 supplementation with resistance training significantly improved lipid profiles, inflammation markers, ...

Diabetes Care Bromocriptine: A Sympatholytic, D2-dopamine Agonist for the Treatment of Type 2 Diabetes Ralph A. DeFronzo, MD Disclosures Diabetes Care. 2011;34 (4):789-794.

Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway Provided by GlobeNewswire Jun 16, 2025, 4:00:00 AM ...

MIAMI, FL / ACCESS Newswire / June 25, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapeutics for n ...

MONTEVIDEO, Uruguay, June 16, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, today announced the publication of ...

Discover 6 protein-rich foods scientifically proven to reduce stress hormones and boost resilience naturally without medication or supplements needed.

Researchers (Wu et al., 2020) demonstrated that betaine reduces intestinal damage and intestinal permeability, thereby limiting the entry of intestinal-derived LPS into the systemic circulation, and ...